, allowing for the generation of mice that express germline hypomorphic levels (<40%) of SOX2 protein and that faithfully recapitulate SOX2 haploinsufficient human phenotypes. We find that Sox2 hypomorphism significantly disrupts the development of the posterior hypothalamus, resulting in an ectopic protuberance of the prechordal floor, an upregulation of Shh signaling, and abnormal hypothalamic patterning.
Introduction
SOX2 is a member of the SRY-related Box family of transcription factors. It plays a critical role in embryonic development, maintains pluripotency and self-renewal potential in embryonic stem cells, and was recently demonstrated to be able to cooperate with other factors to induce pluripotency in a variety of somatic cell types (Avilion et al., 2003; Takahashi et al., 2007; Lai et al., 2011) . Consistent with the role of SOX2 in the maintenance of neural potential and self-renewal, conditional ablation of Sox2 in retinal progenitors shifts their fate from neural to ciliary epithelial, reducing their potential to differentiate into post-mitotic neurons (Taranova et al., 2006; Matsushima et al., 2011) . As a key regulator of a 0925-4773/$ -see front matter Ó 2012 Elsevier Ireland Ltd. All rights reserved. http://dx.doi.org/10.1016/j.mod.2012.04.001 wide array of morphogenetic processes, SOX2 is essential for the normal development of the CNS, the sensory cells of the inner ear and eye, taste bud cells, the division of early gut and respiratory structures, and branching and epithelial cell differentiation in the lung (Kelberman et al., 2006; Okubo et al., 2006; Taranova et al., 2006; Gontan et al., 2008; Domyan et al., 2011; Engelen et al., 2011) . However, the precise role of SOX2 in the morphogenesis of many of these tissues has not been examined in detail. Specifically, there is a gap in our understanding of how reductions in SOX2 function translate into the morphological defects that are observed in humans with SOX2 haploinsufficiency. This genetic disorder accounts for a significant percentage of cases of anophthalmia, microphthalmia, and coloboma, the latter of which results from a failure of the embryonic optic fissure to fuse (Fantes et al., 2003; Kelberman et al., 2006; Bakrania et al., 2007; Schneider et al., 2009) . Previous research using conditional ablation of Sox2 has demonstrated its importance for maintaining the neural potential of retinal progenitors, but the effects of germline Sox2 hypomorphism on the early stages of ocular development have not been defined (Taranova et al., 2006; Matsushima et al., 2011) . SOX2 haploinsufficient humans also present with diencephalic abnormalities, such as hypothalamic hamartoma (HH), a benign overgrowth of the hypothalamus that is associated with a variety of developmental problems, cognitive deficiencies, and seizures (Freeman, 2003; Kelberman et al., 2006; Wallace et al., 2008) . SOX2 and GLI3 mutations are the only reported genetic causes of human hamartomas; however, given that no animal model exists for HH, our current understanding of how these defects develop is extremely limited from both a morphological and molecular perspective.
Previous analyses of the role of SOX2 in the morphogenesis of the mammalian CNS have primarily relied on the examination of (i) Sox2 heterozygous mice, (ii) mouse lines in which Sox2 is ablated in a spatiotemporally-specific manner, or (iii) mouse lines with mutations affecting Sox2 enhancers (Dong et al., 2002; Ferri et al., 2004; Kiernan et al., 2005; Kelberman et al., 2006; Taranova et al., 2006; Miyagi et al., 2008; Matsushima et al., 2011) . Each of these approaches is limited with respect to their ability to model human SOX2 haploinsufficiency. Sox2 +/À mice do not typically exhibit ocular defects, which are almost ubiquitous in SOX2 haploinsufficient humans, precluding the use of Sox2 +/À mice as a model of SOX2 haploinsufficiency (Avilion et al., 2003; Ellis et al., 2004; Kelberman et al., 2006; Taranova et al., 2006; Schneider et al., 2009) . Moreover, the vast majority of reported human SOX2 haploinsufficiency cases result from mutations in the SOX2 open reading frame, most likely resulting in systemic attenuation of SOX2 function. Therefore, models that make use of restricted modification of Sox2 expression do not recapitulate the genetic environment associated with human SOX2 haploinsufficiency (Schneider et al., 2009 protein levels and exhibit variable anophthalmia and microphthalmia, similar to SOX2 haploinsufficient humans (Ellis et al., 2004; Taranova et al., 2006) . Sox2 HYP mice exhibit a global reduction in SOX2 levels, a genetic environment that mimics that of SOX2 haploinsufficient humans. Here, we present a detailed analysis of Sox2 HYP mice and ascertain the temporal onset of the ocular and diencephalic morphological defects that result from reduced SOX2 dosages. We find that Sox2 HYP embryos exhibit morphological and molecular abnormalities of the posterior prechordal floor, including an upregulation of Shh and a downregulation of Gli3. E10.5 Sox2 HYP embryos exhibit morphological defects of the optic stalk and optic cup (OC), and molecular patterning abnormalities in the retinal primordium. Sox2 HYP eyes exhibit decreased levels of Pax2 and are colobomic, a phenotype that has not been described in a mouse model of Sox2 deficiency. Taken together, these results (i) represent the first characterization of the molecular and morphological phenotype of the SOX2 mutant hypothalamus, a region known to be affected in SOX2 haploinsufficient humans; (ii) establish the morphological and molecular onset of the ocular defects observed in Sox2 HYP mice; and (iii) establish an animal model for SOX2 deficiency-related coloboma.
Materials and methods

Animals
The generation of the Sox2
EGFP alleles has been previously described (Ellis et al., 2004; Taranova et al., 2006 . All of the molecular and scanning electron microscopy (SEM) analyses were performed on a mixed C57BL/6-CD1 (Jackson Laboratories) background. Sox2 HYP mice on this background mice display less severe but similar phenotypes to Sox2 HYP C57BL/6 mice. Whole mount morphological analyses of E13-E14 embryos were performed on a C57BL/6 background. All of the animal work was performed in accordance with University of North Carolina at Chapel Hill DLAM and IACUC approval. The date of vaginal plug was considered E0.5, and precise embryo stages were determined using established somite reference points (Chan et al., 2004) . The presence of the Sox2 EGFP allele was determined visually using a UV fluorescent microscope.
Genotyping protocols
Tissue preparation for SEM analyses
The embryos were processed in a manner similar to that described in Sulik et al., 1994 . Briefly, the embryos were fixed in 2.5% glutaraldehyde, cut manually through the forebrain at or near the level of the optic primordium, and post-fixed for 1-2 h in 2% osmium tetroxide. The samples were then dehydrated in a graded ethanol series and critical point dried using liquid CO 2 . The samples were then mounted on aluminum stubs, manually cleaned of debris, coated with a gold-palladium sputter-coater, and imaged on a JEOL 6300 scanning electron microscope.
2.4.
Tissue preparation for immunohistochemical and in situ hybridization analyses
The embryos were fixed at 4°C in a solution of phosphate buffered saline (PBS) and 4% paraformaldehyde for periods of 2 h to overnight, depending on the stage of the embryo. Following three washes in PBS, the embryos were cryoprotected in a sucrose gradient (10%, 20%, and 30% sucrose in PBS) and mounted in Optimum Cutting Temperature mounting medium (OCT, Tissue-Tek). For immunohistochemical (IHC) analyses, frontal 10 lm sections were blocked in a solution of 1-4% heat-inactivated goat serum and 0.1% Triton X-100 (Sigma). The sections were incubated with primary antibodies overnight at 4°C and with secondary antibodies for 1 h at room temperature. For in situ analyses, 20 lm frontal or horizontal sections were incubated with digoxigenin (DIG)-labeled probes and visualized using enzymatic detection, following the manufacturer's protocol (Roche). The following antibodies were used for this study: rabbit anti-PH3 (1:1000, Abcam), rabbit anti-cleaved capase-3 (1:250, Cell Signaling), and Alexa Fluor 546-conjugated anti-rabbit (1:1000, Molecular Probes). The following in situ hybridization probes were used for this study: Nkx2.1 [Dr. A. Lamantia, (Shimamura et al., 1995) ], Otx1 [Dr. J. P. Martinez-Barbera, (Simeone et al., 1992) ], Pax2 [Dr. J.P. Martinez-Barbera, (Sajedi et al., 2008) (Furukawa et al., 1997) ], Shh (Dr. E. Tucker), Tbx3, [Dr. M. Pontecorvi, (Pontecorvi et al., 2008) ], and Vax2 [Dr. G. Lemke, (Mui et al., 2005) ]. At least three Sox2
CONT and Sox2 HYP embryos were analyzed for each probe.
Measurements and statistics
All of the optic stalk length measurements were made relative to the head width of the embryo at the optic level. E10.5 head-width measurements were made between the points on the surface ectoderm where the maxillary process emerges, immediately ventral to the eye. The optic stalk lengths were measured linearly. All of the distance measurements were made in triplicate using ImageJ software and averaged. The Mendelian ratios were examined with the two-tailed squared test using three degrees of freedom. The cell death and proliferation analyses were performed by computing the ratio of positively stained cells to the total number of cells in a predefined region. Cells were only considered PH3-positive if they were located along the apical edge of the retina. Cells were considered positive for cleaved caspase-3 if staining could be directly associated with a condensed or fragmented nucleus. The results are reported as the mean ± the standard error of the mean. At least three Sox2
CONT and Sox2 HYP embryos were analyzed for cell death and proliferation and for all in situ gene expression analyses. Once the penetrance of the hypothalamic defect was determined, the gene expression analyses were performed on severely affected embryos only (see Fig. 2 legend).
Anatomic nomenclature
The anatomical features referred to below are defined as follows and are diagrammed in Fig. S1 . According to the revised prosomeric model of Puelles and Rubenstein, 2003 the prechordal floor is defined as the ventral-most aspect of the diencephalon and telencephalon, with a caudal limit at the posterior edge of the retromammillary area. The mammillary area is defined as the region surrounding the mammillary body anlage, which is located near the posterior limit of the prechordal floor. The mammillary pouch is defined as the invagination of the prechordal floor within the mammillary area and was used as a morphological landmark for the expression analyses (García-Calero et al., 2006) . The tuberal hypothalamus is defined as the region of the prechordal floor anterior to the mammillary area and posterior to the infundibulum (Shimamura et al., 1995) . The ciliary margin of both E10.5 and E16.5 retinas is defined as the distal aspect of the retina. (Taranova et al., 2006) . Given that SOX2 is required for the survival of the peri-implantation embryo, we analyzed genotypic ratios at different embryonic stages (E9.5-E18) to determine whether Sox2 HYP embryos display increased embryonic lethality. Sox2-HYP embryos are recovered at the expected Mendelian ratio (Table S1 ). To determine whether overall development is delayed in Sox2 HYP embryos, somite counts for E9.5 and E10.5 litters were tabulated and found to be similar between Sox2
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3
CONT and Sox2 HYP embryos (Table S1 ). These results indicate that (i)
Sox2 deficiency does not lead to embryonic lethality, and (ii) the morphological defects observed in Sox2 HYP mice are not the result of a developmental delay (See Table S1 ).
3.2 The diencephalic prechordal floor is laterally expanded in E10.5 Sox2 HYP embryos SOX2 haploinsufficient humans exhibit HH, an overgrowth of the posteroventral diencephalon. Given the complex and dynamic morphology of the developing diencephalon, we used SEM to analyze this region in E9.5 and E10.5 Sox2 HYP embryos. The SEM data revealed that the posterior prechordal floor is broader in Sox2 HYP embryos as early as E9.5 (Fig. S1D vs. E and F). By E10.5, two evaginations are visible in the Sox2-CONT prechordal floor; the infundibulum, which is the precursor of the posterior and infundibular lobes of the pituitary, and the more posterior mammillary pouch ( Fig. 1 and Fig. S2 ). SEM images of E10.5 Sox2 HYP embryos revealed that the infundibulum is broadened (Fig. 1D vs. E and F). The infundibular widths were determined from measurements of histological sections, which confirmed a statistically signif- ( Fig. 1D vs. F, arrowhead). These SEM analyses provide the first insight into the effects SOX2 deficiency on the morphological development of the posterior prechordal floor, a tissue that is affected in SOX2 haploinsufficient humans (Kelberman et al., 2006) .
3.3.
Shh signaling and hypothalamic patterning are disrupted in the E12.5 Sox2 HYP prechordal floor E12.5 Sox2 HYP embryos were analyzed histologically at the level of the tuberal hypothalamus, revealing a protuberance along the prechordal floor. Given that GLI3 has been implicated in human HHs, we examined Gli3 expression in the E12.5 Sox2 HYP hypothalamic anlage (Wallace et al., 2008) . In
Sox2
CONT embryos, Gli3 is not expressed along the prechordal floor from its caudal limit to approximately 60 lm anterior to the mammillary pouch; however, Gli3 is expressed rostral to this point ( Fig. 2A and C) . In Sox2 HYP embryos, however, Gli3 is absent from the prechordal floor along nearly the entire length of the tuberal hypothalamus ( Fig. 2B and D) . Gli3 and Shh have been demonstrated to be mutually antagonistic in several CNS regions, including the developing spinal cord and telencephalon (Litingtung and Chiang, 2000; Rallu et al., 2002) . Consistent with these previous findings, Shh exhibits a nearly mutually exclusive expression pattern to Gli3 along the prechordal floor of E12.5 Sox2 CONT embryos, i.e., it is expressed only at low levels in the mammillary region but is downregulated approximately 60 lm anterior to the mammillary pouch ( Fig. 2A and E) . In contrast, Shh expression is observed as far as 300 lm anterior to the mammillary pouch in Sox2 HYP embryos (Fig. 2B and F) .
To determine the cell identity of the hypothalamic protuberance in Sox2 HYP embryos, we examined the expression of hypothalamic and neural progenitor markers. Examination of the expression of the hypothalamic progenitor marker Nkx2.1 revealed that this gene is expressed anterior to the mammillary region along the prechordal floor in Sox2 CONT embryos but is absent in the protuberance of the prechordal floor observed in Sox2 HYP embryos (Fig. 2G vs. H) . We next examined Sox2 CONT and Sox2 HYP embryos for the expression of markers that define and maintain neural progenitor identity: N-cadherin and Sox2 itself (Graham et al., 2003; Zhang et al., 2010) . N-cadherin is expressed normally along the prechordal floor of Sox2 HYP embryos, indicating that these cells have maintained a neural progenitor identity (Fig. 2I vs. J). Uniform expression of Sox2 is observed along the prechordal floor of Sox2 CONT embryos (Fig. 2K ). Sox2 expression is also present throughout most of the neuroepithelium of Sox2 HYP embryos but is nearly undetectable along the prechordal floor of the tuberal hypothalamus (Fig. 2K vs. L). At E14.5, the protuberance in the Sox2 HYP tuberal hypothalamus remains the same size as at E12.5; however, the Nkx2.1 and Shh expression patterns are unaffected ( Fig. S4B and D) . These analyses indicate that morphological defects observed in the prechordal floor of Sox2 HYP embryos are associated with disrupted Shh signaling and abnormal hypothalamic patterning. 
3.4.
The retinal primordium of E10.5 Sox2 HYP embryos is morphologically abnormal
To determine the onset of the optic malformations observed in Sox2 HYP mice, we performed whole-mount and/or SEM analyses of embryos between E9.5 and E14.5. At E9.5, no clear differences can be discerned between the optic vesicles of whole mount Sox2 CONT and Sox2 HYP embryos (Fig. S2A-C ). Sox2 HYP embryos first exhibit readily discernable morphological defects at E10.5, during formation of the OC. In Sox2-EGFP/+ embryos, the EGFP reporter permits visualization of the neural retina as a ring of tissue surrounding the circular, SOX2-positive invaginating lens (Fig. 3A) . In Sox2 HYP embryos, however, the ventral aspect of the retina cannot be discerned through the surface ectoderm (Fig. 3D) . By E13.5 Sox2 HYP embryos exhibit coloboma, a persistence of the ventral optic fissure (Fig. 3B vs. E). Severely affected Sox2 HYP embryos develop anophthalmia by E14.5, with only pigmented epithelial cells remaining (Fig. 3C vs. F).
To determine the nature of the ventral OC defects observed in whole mount E10.5 Sox2 HYP embryos, we performed SEM analysis of the optic anlage. In Sox2 CONT embryos, the ventral aspect of the OC is in close opposition to the surface ectoderm ( Fig. 4A and D) . Sox2 HYP OCs, however, often exhibit an abnormal morphology, such that there is an increased separation between the ventral OC and the surface ectoderm (Fig. 4A, D vs . B, C, E and F), explaining why the ventral OC cannot be discerned through the surface ectoderm in Sox2 HYP embryos (Fig. 3B) .
Given that E14.5 and later-stage Sox2 HYP embryos exhibit microphthalmia or anophthalmia, we analyzed cell number, proliferation and apoptosis in E9.5 and E10.5 retinal progenitors using Hoechst, phospho-histone H3 (PH3), and cleaved caspase-3, respectively. We find that cell number, proliferation, and apoptosis are not significantly affected in the presumptive retina of E9.5 or E10.5 Sox2 HYP embryos (Fig. S5A-M define a requirement for SOX2 in the development of the mammalian optic stalk.
Characterization of the patterning of Sox2
HYP neural retinas at two developmental stages
Given that many animal models of ocular defects exhibit abnormal molecular patterning of the retina and/or optic stalk, we next determined whether molecular patterning was disrupted in the E10.5 Sox2 HYP optic anlage. We examined the expression of proximal/ventral markers (Pax2, Vax2), which label the ventral optic stalk and ventral retina, the dorsal retina marker Tbx3, and a marker of the ciliary margin and retinal pigmented epithelium (RPE) (Otx1) (Nornes et al., 1990; Barbieri et al., 1999; Martinez-Morales et al., 2001; Sowden et al., 2001 ). The expression of Pax6, which is present in the retina in a high-distal/low-proximal gradient, and Rax, which marks all retinal progenitors at this stage, were also examined (Mathers et al., 1997; Bä umer et al., 2002 : Matsushima et al., 2011 . In the dorsal and ventral OC of Sox2 HYP embryos, Tbx3 ( Fig. 6A and B) and Vax2 ( Fig. 6C and D) , respectively, mimic the expression patterns observed in Sox2 CONT embryos.
Within the Sox2 HYP OC, Pax6 expression is increased ( Fig. 6E and F) and Rax expression is largely unaffected (Fig. 6G and H). Given that (i) Pax2 is associated with coloboma in humans and mice and (ii) PAX6 and PAX2 are mutually antagonistic in the developing retina, we examined the expression of Pax2 in Sox2 CONT and Sox2 HYP embryos (Sanyanusin et al., 1995; Torres et al., 1996; Schwarz et al., 2000) . Whereas Pax2 is strongly expressed in the ventral OC of Sox2 CONT embryos, it is strongly downregulated in the Sox2 HYP OC (Fig. 6I and J) . To determine whether the ciliary margin and RPE are correctly specified in Sox2 HYP embryos, we examined the expression of Otx1, which is normally expressed in the distal ciliary margin and the RPE. In Sox2 CONT embryos at E10.5, Otx1 expression is restricted to the distal retina and the RPE (Fig. 6K) . In E10.5 Sox2 HYP OCs,
Otx1 expression is normal in the RPE but is expanded into the central neural retina (Fig. 6L) .
To determine the fate of the distalized, Otx1-expressing cell population observed in E10.5 Sox2 HYP OCs, we examined marker expression in the E16.5 neural retina and ciliary margin. In Sox2 CONT eyes at E16.5, the neural progenitor marker Notch1 is expressed in the neuroblast layer of the central retina but is excluded from the ciliary margin ( Fig. 7A and B) (de la Pompa et al., 1997) . In Sox2 HYP eyes, however, a greater extent of the distal retina is Notch1-negative ( Fig. 7C and D) . Instead, this tissue is positive for the ciliary margin marker Otx1 and exhibits an epithelial morphology that is consistent with a ciliary margin identity (Fig. 7E , F vs. G and H). These molecular data suggest that the Sox2 HYP retinal primordium is patterned normally at E10.5, but that (i) Pax6 expression is expanded at the expense of Pax2; and (ii) at both E10.5 and E16.5, cells in the distal retina have transitioned from a neural to a ciliary margin identity.
Discussion
Here, we present the first analyses of early hypothalamic and ocular development in a mouse model of human SOX2 haploinsufficiency, a genetic disorder characterized by severe diencephalic and ocular defects. These findings indicate that SOX2 is required for the proper morphogenesis and molecular patterning of the posterior prechordal plate, optic stalk and OC. Furthermore, these results (i) define the morphological and temporal onset of the defects observed in Sox2 embryos, and (ii) identify Shh signaling as a potential mediator of these abnormalities. In humans, SOX2 haploinsufficiency causes abnormalities in several brain regions, including the hypothalamus, optic nerve, and eyes (Kelberman et al., 2006) . The nature and timing of the onset of these defects are unknown, as are the downstream pathways that are involved in mediating their development. We generated Sox2 HYP embryos to directly address these questions, and thereby identified novel functions for SOX2 in the morphogenesis and molecular patterning of the diencephalon and the eye. The generation and detailed molecular analysis of Sox2 HYP embryos provide an understanding of the molecular nature and temporal onset of the defects observed in SOX2 haploinsufficient humans. Hypothalamic hamartomas are benign overgrowths of the ventral hypothalamus and are associated with a variety of developmental problems, cognitive deficiencies, and seizures (Freeman, 2003) . In this study, we used SEM to obtain threedimensional, high-resolution images of the Sox2 HYP hypothalamus, and observed that E10.5 Sox2 HYP embryos exhibit a broad diencephalic prechordal floor from the mammillary area to the infundibulum. This region encompasses the tuberal region of the hypothalamus, which is associated with HHs in humans (Booth et al., 2004; Schneider et al., 2009 ). In E12.5 Sox2 HYP embryos, this expansion manifests as a protuberance into the lumen of the neural tube. The morphogen Shh acts as a powerful patterning agent along the length of the mouse neural tube, including the hypothalamus (Briscoe et al., 1999; Szabó et al., 2009 ). However, in contrast to much of the ventral midline, Shh expression is normally excluded from the posterior prechordal floor (Shimamura et al., 1995) . Gli3, a member of the Gli family of transcription factors, has been demonstrated in several contexts to antagonize Shh signaling; a loss of Gli3 in mouse leads to an upregulation of Shh in the developing spinal cord (Ruiz i Altaba, 1998), and Shh and Gli3 have been shown to be functionally antagonistic in the mouse forebrain (Rallu et al., 2002) . Consistent with these findings, Gli3 is normally expressed in the Shh-negative hypothalamic prechordal floor, and a loss of GLI3 expression in humans has been shown to result in HH. Molecular analysis of the protuberance observed in Sox2 HYP embryos indicates that the cells at its apex ectopically express Shh and abnormally downregulate Gli3. These results raise the intriguing possibility that the hypothalamic defects that are observed in SOX2 haploinsufficient humans result from a dysregulation of Shh signaling. Sox2 HYP embryos recover normal molecular patterning in the hypothalamus by late gestational stages, consistent with the observation that Gli3-deficient mice, despite exhibiting nearly all of the defects that are associated with human GLI3 mutations, are not reported to exhibit HH (Bö se et al., 2002) . These data suggest a murine-specific compensatory mechanism in the hypothalamus. Our results also address the question of why the ventral hypothalamus is more severely affected by SOX2 deficiency than are other regions of the diencephalon. We find that that Sox2 expression is nearly eliminated in the prechordal floor of Sox2 HYP embryos, which may reflect Sox2 autoregulation and explain the apparent hypersensitivity of this tissue to SOX2 deficiency. Consistent with this interpretation, evidence for SOX2 autoregulation has been observed in mouse and chick neural stems cells (Miyagi et al., 2004 : Miyagi et al., 2006 . Ocular defects are by far the most commonly described phenotypes in SOX2 haploinsufficient humans and range from coloboma to bilateral anophthalmia (Ragge et al., 2005; Wang et al., 2008; Schneider et al., 2009) . However, there is currently no description of the effects of germline Sox2 deficiency on oculogenesis earlier than E13.5 in mouse, by which point mature retinal morphology has been established. Specifically, it is unknown what role SOX2 plays in the development of the OC or the optic stalk. We report that the ventral OCs of E10.5 Sox2 HYP embryos are abnormally separated from the surface ectoderm but do not exhibit decreased cell number or proliferation or increased cell death. These data suggest that a hypoplastic ventral optic stalk leads to abnormal OC morphology. Indeed, we find that Sox2 HYP optic stalks are shorter and exhibit increased cell death. These results are the first to define a role for SOX2 in optic stalk morphogenesis and indicate that germline Sox2 deficiency can disrupt OC morphogenesis by causing optic stalk hypoplasia. The role of SOX2 in the maintenance of neural competency is well established, although it is unknown how germline Sox2 hypomorphism affects early retinal development (i.e., prior to E13.5) (Avilion et al., 2003; Favaro et al., 2009 ). Recent work from our laboratory demonstrated that conditional ablation of Sox2 from the neural retina at E10.5 using the Pax6a enhancer-driven Cre results in the conversion of the retinal neuroepithelium to non-neural ciliary epithelium (Marquardt et al., 2001; Taranova et al., 2006; Matsushima et al., 2011) . These data also demonstrate that SOX2 and PAX6 are mutually antagonistic in the retina, respectively promoting neural and ciliary fates. Distal (i.e., ciliary) identity is indicated by Otx1 expression and high expression levels of Pax6 (Martinez-Morales et al., 2001; Matsushima et al., 2011) . We demonstrate that although overall patterning of the neural retina is maintained at E10.5, the expression of Otx1 is centrally expanded, and Pax6 is upregulated in the Sox2 HYP retina at this stage. These results indicate that retinal neural progenitors exhibit the first molecular indications of a loss of neuronal competency at E10.5 in the absence of the full complement of SOX2 dosage, defining a temporal requirement for SOX2 in the establishment of neural fate in the mouse OC. Consistent with the results of the E10.5 expression analyses, E16.5 Sox2 HYP eyes lack expression of the neural progenitor marker Notch1 in the distal retina. Instead, this region expresses Otx1 and exhibits an epithelial morphology consistent with a ciliary margin identity. The ciliary fate transition that is observed in Sox2 HYP retinas is intriguing in that it suggests a mechanism by which microphthalmia develops, i.e., the expansion of the more slowly proliferating, non-neural, ciliary epithelium would be expected to result in a smaller retina; however, this hypothesis will have to be directly addressed. Coloboma is a ventral eye deformity that frequently afflicts human carriers of SOX2 mutations but which has not been described in a mouse model of SOX2 deficiency (Schneider et al., 2009) . PAX2 is also associated with coloboma in humans and mouse, and its expression is strongly downregulated in the ventral Sox2 HYP OC (Sanyanusin et al., 1995; Torres et al., 1996) , suggesting a mechanism by which SOX2 deficiency results in coloboma.
The question naturally arises of why certain regions of the neuroepithelium are more severely affected by SOX2 deficiency than others. One possible explanation involves the other SOXB1 family members, SOX1 and SOX3, which are also broadly expressed in the developing neural tube, where their functions are thought to be partially redundant (Wood and Episkopou, 1999; Bylund et al., 2003; Graham et al., 2003) . However, SOX1 and SOX3 are not expressed in the neural retina following OC invagination, and SOX1 is excluded from the ventral midline (Kamachi et al., 1998; Aubert et al., 2003) . Given that these two tissues are the most severely affected in Sox2 HYP embryos, these expression profiles fit a model in which (i) a certain degree of SOXB1 dosage is required in all regions of the neural epithelium; and (ii) the neural retina and the ventral midline are the most sensitive tissues to SOX2-deficiency. The phenotypes of SOX3 and SOX1-deficient mice are consistent with this hypothesis (Malas et al., 2003; Rizzoti et al., 2004; Donner et al., 2007) . In summary, this is the first study to describe early diencephalic and optic development in a mouse model of human SOX2 haploinsufficiency. Our results demonstrate that SOX2 is required for proper formation and patterning of the prechordal floor, optic stalk, and the OC. All of the phenotypes of Sox2 HYP embryos recapitulate those described in SOX2 haploinsufficient humans. Furthermore, this work provides significant insights into the temporal and molecular requirements for SOX2 in the morphogenesis and patterning of the mammalian CNS.
